InvestorsHub Logo

drugmanrx

12/06/19 10:06 AM

#81948 RE: dms1 #81944

Not saying this is happening here, but here is an example how QTMM can have an R&D department without paying for one.

I'm curious why you think a company that spent $36,000 on R&D during the last quarter they reported has an R&D department.



Per SEC filings

CCA and the University of Pennsylvania ("PENN") and the Children's Hospital of Philadelphia ("Children's Hospital") are engaged in a co-development alliance which is combining CCA's NPC technology with other PENN and Children's Hospital technologies to co-develop technologies to be jointly owned by CCA, PENN and Children's Hospital, including compounds to treat, and to a certain extent, prevent traumatic brain injury. This alliance also entails development involving dendrites, neurodevelopment, bone morphogenetic proteins, glutamate excitotoxicity, neural regeneration, injury-induced altered brain excitability, circuit rearrangement and synaptic function, including the development of pharmaceuticals."



Well actually the India's licensing agreement does show it will be happening here.



Section 3.1 License Grant. The Licensor hereby grants to the Licensee a [non-]exclusive license under and to the Licensed Technology to Commercialize, Develop, export, import, make or have made, Manufacture, offer for sale, sell and use Licensed Products, within the Field of Use and in the Territory (the “License”). The foregoing License shall be exclusive with respect to the production of Licensed Products within the State of Assam, Republic of India

Does Quantum dots Key fall within the field of use?